Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Diaceutics ( (GB:DXRX) ) has provided an update.
Diaceutics PLC has announced that its Global Shares Trustees and Zedra Trust Company have acquired ordinary shares on behalf of certain employees as part of the company’s Share Incentive Plan (SIP) schemes. The company has matched these purchases with an equivalent number of shares, indicating a commitment to employee investment and engagement. Following these transactions, Diaceutics has 84,780,127 shares in issue, which stakeholders can use as a reference for shareholding notifications under the FCA’s regulations.
More about Diaceutics
Diaceutics PLC is a leading technology and solutions provider focused on the pharma and biotech industry. The company offers an end-to-end commercialization solution for precision medicines through data analytics, scientific, and advisory services, supported by their platform DXRX – The Diagnostics Network.
YTD Price Performance: 22.63%
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $142.3M
See more insights into DXRX stock on TipRanks’ Stock Analysis page.
